XML 69 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
Organization and Significant Accounting Policies, Cash, Cash Equivalents and Investments (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
Company
Dec. 31, 2020
USD ($)
Investment
Dec. 31, 2019
USD ($)
Cash, Cash Equivalents and Investments [Abstract]      
Number of publicly held companies in which there is an equity ownership interest of less than 20% | Company 3    
Number of privately held companies in which there is an equity ownership interest of less than 20% | Company 7    
Number of investments in privately held companies that were revalued | Investment   3  
Gain on investment $ 10,103 $ 16,540 $ 192
Dynacure [Member]      
Cash, Cash Equivalents and Investments [Abstract]      
Gain on investment   6,300  
Suzhou-Ribo [Member]      
Cash, Cash Equivalents and Investments [Abstract]      
Gain on investment   3,000  
Aro Biotherapeutics [Member]      
Cash, Cash Equivalents and Investments [Abstract]      
Gain on investment   $ 5,500